Newborn Screenings for Spinal Muscular Atrophy (SMA) and Treatment Brings Hope
All babies born in Minnesota are now being screened for spinal muscular atrophy (SMA) unless their parents opt out of the newborn screening, the Minnesota Department of Health recently announced. SMA is the leading genetic cause of early childhood death in the United States.
One of the nation's leaders in pushing to develop a screening and helping SMA families is Gillette pediatric neurologist and neuromuscular clinic director Randal Richardson, MD. He and his team are part of the cutting-edge research into Spinraza ™, also called nusinersen, a drug to treat SMA.